Form 4 for CYTK CYTOKINETICS INC
Accepted 2024-03-18 00:00:00 ET · period of report 2024-03-14 · accession 0001127602-24-010516 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-18 | 2024-03-14 | CYTK | Malik Fady Ibraham | EVP Research, Development | A - Grant | $0.00 | +21.3K | 142.6K | +18% | $0 |
| DM | 2024-03-18 | 2024-03-14 | CYTK | Malik Fady Ibraham | EVP Research, Development | A - Grant | $0.00 | +24.6K | 23.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-14 | A | A | 21,333 | $0.00 | 142,567 | D | — | — | |
| 2 | Derivative | Incentive Stock Option (Right to Buy) | 2024-03-14 | A | A | 1,541 | $0.00 | 1,541 | D | $63.75 · 2024-04-15 to 2034-03-13 | 1,541 Common Stock | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2024-03-14 | A | A | 23,103 | $0.00 | 23,103 | D | $63.75 · 2024-04-15 to 2034-03-14 | 23,103 Common Stock |